-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
-
-
-
-
-
-
-
Esperion Announces $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Esperion Announces Closing of $225 Million Public Offering
-
-
-
-
-
-
-
Pre-Open Movers 05/06: (AQ) (SBGI) (ESPR) Higher; (CYTK) (FLR) (PETS) (more...)
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

